Wart war: vitamin D3 or acyclovir injections – which works better?

NCT ID NCT07448844

Recruiting now Disease control Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tests whether injecting acyclovir (an antiviral drug) or vitamin D3 directly into skin warts can clear them. Forty people aged 12 and older with common, plantar, flat, or nail warts will receive injections every two weeks for up to four sessions. The main goal is to see which treatment leads to complete wart clearance by week 8.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: acyclovir or vitamin D3 injected into the wart
What this could lead to: If it works, this could point toward a simple, affordable injection treatment for common skin warts.
What could go wrong: This is a small, early-phase trial with only 40 people, so results may not apply to everyone. Warts may come back, and injections can be painful or cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMON WART are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

common wart plantar wart

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMMON WART COMMON WARTS (VERRUCA VULGARIS) FLAT WART PLANTAR WART VIRAL WART WART WARTS HAND WARTS OF FOOT

Contacts and locations

Locations

Railway General Hospital, Railway Carriage Factory Rd, Railway Scheme 7, Rawalpindi
RECRUITING

Rawalpindi, Punjab Province, 46000, Pakistan
Riphah International Hospital, Islamabad Expy, Sector A DHA Phase 5, Islamabad
RECRUITING

Islamabad, 44000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.